LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 3 of total 3

Search options

  1. Article: [CHANGE IN BCL-2 PROTEIN EXPRESSION IN NEURONS OF THE HIPPOCAMPAL AREAS AFTER THE APPLICATION OF ISCHEMIC CEREBRAL POSTCONDITIONING].

    Shcherbak, N S / Rusakova, A G / Galagudza, M M / Yukina, G Yu / Barantsevich, Ye R / Thomson, V V / Shlyakhto, Ye V

    Morfologiia (Saint Petersburg, Russia)

    2015  Volume 148, Issue 5, Page(s) 21–27

    Abstract: Bcl-2 protein expression was studied in hippocampal CA1, CA2, CA3 and CA4 pyramidal neurons in Mongolian gerbils (Meriones unguiculatus), of the in in the early (Day 2) and late (Day 7) reperfusion period after a 7-minute forebrain ischemia and following ...

    Abstract Bcl-2 protein expression was studied in hippocampal CA1, CA2, CA3 and CA4 pyramidal neurons in Mongolian gerbils (Meriones unguiculatus), of the in in the early (Day 2) and late (Day 7) reperfusion period after a 7-minute forebrain ischemia and following ischemic postconditioning (IPostC), as well as in sham-operated animals (n=60). In the latter, the highest level, of Bcl-2-expression was found in CA4 neurons, while the lowest--in-CA1 neurons (P<0.01). Reversible ischemic brain damage led to the increasing deficit of morphologically unchanged hippocampal neurons with the increasing duration of reperfusion period. This was accompanied by a significant decrease in expression of Bcl-2 in the early reperfusion period, but in the late reperfu- sion period this decrease largely disappeared. IPostC, applied as three episodes of ischemia-reperfusion lasting 15/15 seconds, contributed to significant increase in the number of morphologically unchanged CA1 and CA3 neurons in the early reperfusion period, while the expression of Bel-2 was increased in morphologically unchanged neurons in all the hippocampal areas. In the late reperfusion period after IPostC, the number of unchanged neurons was increased in hippocampal areas CA1, CA3 and CA4 (P<0.05), while a significant increase in Bcl-2 expression (by 12.7%, P<0.01) was detected only in CA1 neurons. The results suggest that the cytoprotective effect of IPostC in hippocampal CA1 area is realized through a mechanism leading to increased expression of Bcl-2 protein, i.e., by blocking apoptosis.
    MeSH term(s) Animals ; Gene Expression Regulation ; Gerbillinae ; Hippocampus/metabolism ; Hippocampus/pathology ; Ischemic Postconditioning ; Nerve Tissue Proteins/biosynthesis ; Neurons/metabolism ; Neurons/pathology ; Proto-Oncogene Proteins c-bcl-2/biosynthesis
    Chemical Substances Nerve Tissue Proteins ; Proto-Oncogene Proteins c-bcl-2
    Language Russian
    Publishing date 2015
    Publishing country Russia (Federation)
    Document type English Abstract ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1155276-1
    ISSN 1026-3543 ; 0004-1947
    ISSN 1026-3543 ; 0004-1947
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: [Use of Statins, Anticoagulants, Antiaggregants and Antiarrhythmic Drugs in Patients With COVID-19. The Agreed Experts' Position of Russian Society of Cardiology, Eurasian Association of Therapists, National Society on Atherothrombosis, Societies of Experts in Urgent Cardiology, Eurasian Arrhythmology Association].

    Shlyakhto, Ye V / Arutyunov, G P / Belenkov, Yu N / Tarlovskaya, E I / Konradi, A O / Panchenko, E P / Yavelov, I S / Tereshchenko, S N / Ardashev, A V / Arutyunov, A G / Grigorieva, N Yu / Dzhunusbekova, G A / Drapkina, O M / Koziolova, N A / Komarov, A L / Kropacheva, E S / Malchikova, S V / Mitkovskaya, N P / Orlova, Ya A /
    Petrova, M M / Rebrov, A P / Sisakian, H / Skibitsky, V V / Sugraliyev, A B / Fomin, I V / Chesnikova, A I / Shaposhnik, I I / Zhelyakov, E G / Kanorskii, S G / Kolotsey, L V / Snezhitskiy, V A

    Kardiologiia

    2020  Volume 60, Issue 6, Page(s) 1180

    Abstract: This article discusses relevant aspects in the treatment of patients with COVID-19. Up-to-date information about principles for administration of statins, antithrombotics, and antiarrhythmics is presented. The authors addressed in detail specific ... ...

    Abstract This article discusses relevant aspects in the treatment of patients with COVID-19. Up-to-date information about principles for administration of statins, antithrombotics, and antiarrhythmics is presented. The authors addressed in detail specific features of reversing heart rhythm disorders in patients with coronavirus infection and the interaction of antiarrhythmic and antiviral drugs. Recommendations are provided for outpatient and inpatient antithrombotic therapy for patients with COVID-19. Issues of antithrombotic and antiviral drug interaction are discussed.
    MeSH term(s) Anti-Arrhythmia Agents/therapeutic use ; Anticoagulants/therapeutic use ; Betacoronavirus ; Cardiology ; Coronavirus Infections/drug therapy ; Coronavirus Infections/epidemiology ; Humans ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use ; Pandemics ; Pneumonia, Viral/drug therapy ; Pneumonia, Viral/epidemiology ; Russia ; Societies, Medical
    Chemical Substances Anti-Arrhythmia Agents ; Anticoagulants ; Hydroxymethylglutaryl-CoA Reductase Inhibitors
    Keywords covid19
    Language Russian
    Publishing date 2020-05-25
    Publishing country Russia (Federation)
    Document type Journal Article ; Practice Guideline
    ZDB-ID 131029-x
    ISSN 0022-9040
    ISSN 0022-9040
    DOI 10.18087/cardio.2020.6.n1180
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: [Use of Statins, Anticoagulants, Antiaggregants and Antiarrhythmic Drugs in Patients With COVID-19. The Agreed Experts' Position of Russian Society of Cardiology, Eurasian Association of Therapists, National Society on Atherothrombosis, Societies of Experts in Urgent Cardiology, Eurasian Arrhythmology Association]

    Shlyakhto, Ye V / Arutyunov, G P / Belenkov, Yu N / Tarlovskaya, E I / Konradi, A O / Panchenko, E P / Yavelov, I S / Tereshchenko, S N / Ardashev, A V / Arutyunov, A G / Grigorieva, N Yu / Dzhunusbekova, G A / Drapkina, O M / Koziolova, N A / Komarov, A L / Kropacheva, E S / Malchikova, S V / Mitkovskaya, N P / Orlova, Ya A /
    Petrova, M M / Rebrov, A P / Sisakian, H / Skibitsky, V V / Sugraliyev, A B / Fomin, I V / Chesnikova, A I / Shaposhnik, I I / Zhelyakov, E G / Kanorskii, S G / Kolotsey, L V / Snezhitskiy, V A

    Kardiologiia

    Abstract: This article discusses relevant aspects in the treatment of patients with COVID-19. Up-to-date information about principles for administration of statins, antithrombotics, and antiarrhythmics is presented. The authors addressed in detail specific ... ...

    Abstract This article discusses relevant aspects in the treatment of patients with COVID-19. Up-to-date information about principles for administration of statins, antithrombotics, and antiarrhythmics is presented. The authors addressed in detail specific features of reversing heart rhythm disorders in patients with coronavirus infection and the interaction of antiarrhythmic and antiviral drugs. Recommendations are provided for outpatient and inpatient antithrombotic therapy for patients with COVID-19. Issues of antithrombotic and antiviral drug interaction are discussed.
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #689072
    Database COVID19

    Kategorien

To top